The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Fosinopril Sodium Market Research Report 2025
Synopsis
Fosinopril is an angiotensin converting enzyme (ACE) inhibitor[1] used for the treatment of hypertension and some types of chronic heart failure.
Global Fosinopril Sodium market is projected to reach US$ 571.9 million in 2029, increasing from US$ 435 million in 2022, with the CAGR of 4.0% during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Fosinopril Sodium market research.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Fosinopril Sodium market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Huahai Pharma
Sino Pharma
Warrant
Viatris
ANI Pharma
Apotex
Aurobindo Pharma
Bristol Myers Squibb
Chartwell Pharma
DOC Generici
Emcure Pharma
Cipla
Menarini
MS Pharma
Pharmascience
Prinston Pharmaceutical Inc.
Segment by Type
Tablets
Capsule
Segment by Application
Hospital
Pharmacy
Other
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
The Fosinopril Sodium report covers below items:
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Manufacturers’ Competition Patterns
Chapter 3: Country Level Sales Analysis
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6: Manufacturers’ Outline
Chapter 7: Industry Chain, Market Channel and Customer Analysis
Chapter 8: Market Opportunities and Challenges
Chapter 9: Market Conclusions
Chapter 10: Research Methodology and Data Source
Fosinopril is an angiotensin converting enzyme (ACE) inhibitor[1] used for the treatment of hypertension and some types of chronic heart failure.
Global Fosinopril Sodium market is projected to reach US$ 571.9 million in 2029, increasing from US$ 435 million in 2022, with the CAGR of 4.0% during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Fosinopril Sodium market research.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Fosinopril Sodium market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Huahai Pharma
Sino Pharma
Warrant
Viatris
ANI Pharma
Apotex
Aurobindo Pharma
Bristol Myers Squibb
Chartwell Pharma
DOC Generici
Emcure Pharma
Cipla
Menarini
MS Pharma
Pharmascience
Prinston Pharmaceutical Inc.
Segment by Type
Tablets
Capsule
Segment by Application
Hospital
Pharmacy
Other
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
The Fosinopril Sodium report covers below items:
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Manufacturers’ Competition Patterns
Chapter 3: Country Level Sales Analysis
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6: Manufacturers’ Outline
Chapter 7: Industry Chain, Market Channel and Customer Analysis
Chapter 8: Market Opportunities and Challenges
Chapter 9: Market Conclusions
Chapter 10: Research Methodology and Data Source
Index1 Fosinopril Sodium Market Overview
1.1 Product Overview and Scope of Fosinopril Sodium
1.2 Fosinopril Sodium Segment by Type
1.2.1 Global Fosinopril Sodium Market Value Comparison by Type (2023-2029)
1.2.2 Tablets
1.2.3 Capsule
1.3 Fosinopril Sodium Segment by Application
1.3.1 Global Fosinopril Sodium Market Value by Application: (2023-2029)
1.3.2 Hospital
1.3.3 Pharmacy
1.3.4 Other
1.4 Global Fosinopril Sodium Market Size Estimates and Forecasts
1.4.1 Global Fosinopril Sodium Revenue 2018-2029
1.4.2 Global Fosinopril Sodium Sales 2018-2029
1.4.3 Global Fosinopril Sodium Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 Fosinopril Sodium Market Competition by Manufacturers
2.1 Global Fosinopril Sodium Sales Market Share by Manufacturers (2018-2023)
2.2 Global Fosinopril Sodium Revenue Market Share by Manufacturers (2018-2023)
2.3 Global Fosinopril Sodium Average Price by Manufacturers (2018-2023)
2.4 Global Fosinopril Sodium Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of Fosinopril Sodium, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Fosinopril Sodium, Product Type & Application
2.7 Fosinopril Sodium Market Competitive Situation and Trends
2.7.1 Fosinopril Sodium Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Fosinopril Sodium Players Market Share by Revenue
2.7.3 Global Fosinopril Sodium Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Fosinopril Sodium Retrospective Market Scenario by Region
3.1 Global Fosinopril Sodium Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Fosinopril Sodium Global Fosinopril Sodium Sales by Region: 2018-2029
3.2.1 Global Fosinopril Sodium Sales by Region: 2018-2023
3.2.2 Global Fosinopril Sodium Sales by Region: 2024-2029
3.3 Global Fosinopril Sodium Global Fosinopril Sodium Revenue by Region: 2018-2029
3.3.1 Global Fosinopril Sodium Revenue by Region: 2018-2023
3.3.2 Global Fosinopril Sodium Revenue by Region: 2024-2029
3.4 North America Fosinopril Sodium Market Facts & Figures by Country
3.4.1 North America Fosinopril Sodium Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Fosinopril Sodium Sales by Country (2018-2029)
3.4.3 North America Fosinopril Sodium Revenue by Country (2018-2029)
3.4.4 United States
3.4.5 Canada
3.5 Europe Fosinopril Sodium Market Facts & Figures by Country
3.5.1 Europe Fosinopril Sodium Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Fosinopril Sodium Sales by Country (2018-2029)
3.5.3 Europe Fosinopril Sodium Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Fosinopril Sodium Market Facts & Figures by Country
3.6.1 Asia Pacific Fosinopril Sodium Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Fosinopril Sodium Sales by Country (2018-2029)
3.6.3 Asia Pacific Fosinopril Sodium Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Fosinopril Sodium Market Facts & Figures by Country
3.7.1 Latin America Fosinopril Sodium Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Fosinopril Sodium Sales by Country (2018-2029)
3.7.3 Latin America Fosinopril Sodium Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Fosinopril Sodium Market Facts & Figures by Country
3.8.1 Middle East and Africa Fosinopril Sodium Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Fosinopril Sodium Sales by Country (2018-2029)
3.8.3 Middle East and Africa Fosinopril Sodium Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Fosinopril Sodium Sales by Type (2018-2029)
4.1.1 Global Fosinopril Sodium Sales by Type (2018-2023)
4.1.2 Global Fosinopril Sodium Sales by Type (2024-2029)
4.1.3 Global Fosinopril Sodium Sales Market Share by Type (2018-2029)
4.2 Global Fosinopril Sodium Revenue by Type (2018-2029)
4.2.1 Global Fosinopril Sodium Revenue by Type (2018-2023)
4.2.2 Global Fosinopril Sodium Revenue by Type (2024-2029)
4.2.3 Global Fosinopril Sodium Revenue Market Share by Type (2018-2029)
4.3 Global Fosinopril Sodium Price by Type (2018-2029)
5 Segment by Application
5.1 Global Fosinopril Sodium Sales by Application (2018-2029)
5.1.1 Global Fosinopril Sodium Sales by Application (2018-2023)
5.1.2 Global Fosinopril Sodium Sales by Application (2024-2029)
5.1.3 Global Fosinopril Sodium Sales Market Share by Application (2018-2029)
5.2 Global Fosinopril Sodium Revenue by Application (2018-2029)
5.2.1 Global Fosinopril Sodium Revenue by Application (2018-2023)
5.2.2 Global Fosinopril Sodium Revenue by Application (2024-2029)
5.2.3 Global Fosinopril Sodium Revenue Market Share by Application (2018-2029)
5.3 Global Fosinopril Sodium Price by Application (2018-2029)
6 Key Companies Profiled
6.1 Huahai Pharma
6.1.1 Huahai Pharma Corporation Information
6.1.2 Huahai Pharma Description and Business Overview
6.1.3 Huahai Pharma Fosinopril Sodium Sales, Revenue and Gross Margin (2018-2023)
6.1.4 Huahai Pharma Fosinopril Sodium Product Portfolio
6.1.5 Huahai Pharma Recent Developments/Updates
6.2 Sino Pharma
6.2.1 Sino Pharma Corporation Information
6.2.2 Sino Pharma Description and Business Overview
6.2.3 Sino Pharma Fosinopril Sodium Sales, Revenue and Gross Margin (2018-2023)
6.2.4 Sino Pharma Fosinopril Sodium Product Portfolio
6.2.5 Sino Pharma Recent Developments/Updates
6.3 Warrant
6.3.1 Warrant Corporation Information
6.3.2 Warrant Description and Business Overview
6.3.3 Warrant Fosinopril Sodium Sales, Revenue and Gross Margin (2018-2023)
6.3.4 Warrant Fosinopril Sodium Product Portfolio
6.3.5 Warrant Recent Developments/Updates
6.4 Viatris
6.4.1 Viatris Corporation Information
6.4.2 Viatris Description and Business Overview
6.4.3 Viatris Fosinopril Sodium Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Viatris Fosinopril Sodium Product Portfolio
6.4.5 Viatris Recent Developments/Updates
6.5 ANI Pharma
6.5.1 ANI Pharma Corporation Information
6.5.2 ANI Pharma Description and Business Overview
6.5.3 ANI Pharma Fosinopril Sodium Sales, Revenue and Gross Margin (2018-2023)
6.5.4 ANI Pharma Fosinopril Sodium Product Portfolio
6.5.5 ANI Pharma Recent Developments/Updates
6.6 Apotex
6.6.1 Apotex Corporation Information
6.6.2 Apotex Description and Business Overview
6.6.3 Apotex Fosinopril Sodium Sales, Revenue and Gross Margin (2018-2023)
6.6.4 Apotex Fosinopril Sodium Product Portfolio
6.6.5 Apotex Recent Developments/Updates
6.7 Aurobindo Pharma
6.6.1 Aurobindo Pharma Corporation Information
6.6.2 Aurobindo Pharma Description and Business Overview
6.6.3 Aurobindo Pharma Fosinopril Sodium Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Aurobindo Pharma Fosinopril Sodium Product Portfolio
6.7.5 Aurobindo Pharma Recent Developments/Updates
6.8 Bristol Myers Squibb
6.8.1 Bristol Myers Squibb Corporation Information
6.8.2 Bristol Myers Squibb Description and Business Overview
6.8.3 Bristol Myers Squibb Fosinopril Sodium Sales, Revenue and Gross Margin (2018-2023)
6.8.4 Bristol Myers Squibb Fosinopril Sodium Product Portfolio
6.8.5 Bristol Myers Squibb Recent Developments/Updates
6.9 Chartwell Pharma
6.9.1 Chartwell Pharma Corporation Information
6.9.2 Chartwell Pharma Description and Business Overview
6.9.3 Chartwell Pharma Fosinopril Sodium Sales, Revenue and Gross Margin (2018-2023)
6.9.4 Chartwell Pharma Fosinopril Sodium Product Portfolio
6.9.5 Chartwell Pharma Recent Developments/Updates
6.10 DOC Generici
6.10.1 DOC Generici Corporation Information
6.10.2 DOC Generici Description and Business Overview
6.10.3 DOC Generici Fosinopril Sodium Sales, Revenue and Gross Margin (2018-2023)
6.10.4 DOC Generici Fosinopril Sodium Product Portfolio
6.10.5 DOC Generici Recent Developments/Updates
6.11 Emcure Pharma
6.11.1 Emcure Pharma Corporation Information
6.11.2 Emcure Pharma Fosinopril Sodium Description and Business Overview
6.11.3 Emcure Pharma Fosinopril Sodium Sales, Revenue and Gross Margin (2018-2023)
6.11.4 Emcure Pharma Fosinopril Sodium Product Portfolio
6.11.5 Emcure Pharma Recent Developments/Updates
6.12 Cipla
6.12.1 Cipla Corporation Information
6.12.2 Cipla Fosinopril Sodium Description and Business Overview
6.12.3 Cipla Fosinopril Sodium Sales, Revenue and Gross Margin (2018-2023)
6.12.4 Cipla Fosinopril Sodium Product Portfolio
6.12.5 Cipla Recent Developments/Updates
6.13 Menarini
6.13.1 Menarini Corporation Information
6.13.2 Menarini Fosinopril Sodium Description and Business Overview
6.13.3 Menarini Fosinopril Sodium Sales, Revenue and Gross Margin (2018-2023)
6.13.4 Menarini Fosinopril Sodium Product Portfolio
6.13.5 Menarini Recent Developments/Updates
6.14 MS Pharma
6.14.1 MS Pharma Corporation Information
6.14.2 MS Pharma Fosinopril Sodium Description and Business Overview
6.14.3 MS Pharma Fosinopril Sodium Sales, Revenue and Gross Margin (2018-2023)
6.14.4 MS Pharma Fosinopril Sodium Product Portfolio
6.14.5 MS Pharma Recent Developments/Updates
6.15 Pharmascience
6.15.1 Pharmascience Corporation Information
6.15.2 Pharmascience Fosinopril Sodium Description and Business Overview
6.15.3 Pharmascience Fosinopril Sodium Sales, Revenue and Gross Margin (2018-2023)
6.15.4 Pharmascience Fosinopril Sodium Product Portfolio
6.15.5 Pharmascience Recent Developments/Updates
6.16 Prinston Pharmaceutical Inc.
6.16.1 Prinston Pharmaceutical Inc. Corporation Information
6.16.2 Prinston Pharmaceutical Inc. Fosinopril Sodium Description and Business Overview
6.16.3 Prinston Pharmaceutical Inc. Fosinopril Sodium Sales, Revenue and Gross Margin (2018-2023)
6.16.4 Prinston Pharmaceutical Inc. Fosinopril Sodium Product Portfolio
6.16.5 Prinston Pharmaceutical Inc. Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Fosinopril Sodium Industry Chain Analysis
7.2 Fosinopril Sodium Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Fosinopril Sodium Production Mode & Process
7.4 Fosinopril Sodium Sales and Marketing
7.4.1 Fosinopril Sodium Sales Channels
7.4.2 Fosinopril Sodium Distributors
7.5 Fosinopril Sodium Customers
8 Fosinopril Sodium Market Dynamics
8.1 Fosinopril Sodium Industry Trends
8.2 Fosinopril Sodium Market Drivers
8.3 Fosinopril Sodium Market Challenges
8.4 Fosinopril Sodium Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
